CG Oncology's top three insider shareholders as of April 17, 2026 are Hong Fang Song (Director, 5.84Mn shares), Capital Global Life Sciences Fund Iv, L.P. Decheng (TenPercentOwner, 4.96Mn shares), Brian Guan-Chyun Liu (Director, 1.52Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Hong Fang Song | - | 0 | 5,838,167 | 04 Sep, 2025 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 4,958,810 | 0 | 09 Apr, 2024 |
| Brian Guan-Chyun Liu | - | 0 | 1,515,151 | 12 Sep, 2025 |
| Hong Fang Song | - | 613,928 | 0 | 31 Jan, 2024 |
| Hong Fang Song | - | 0 | 586,982 | 30 Aug, 2024 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 0 | 400,000 | 31 Jan, 2024 |
| Arthur Kuan | Chief Executive Officer | 198,916 | 0 | 13 Mar, 2026 |
| Corleen M. Roche | Cfo Secretary | 2,000 | 0 | 31 Jan, 2024 |
| Vijay Kasturi | Chief Medical Officer | 1,315 | 0 | 31 Jan, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | James Mulay | Common Stock | A | 654 | $3.72 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 654 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Common Stock | A | 1,310 | $12.59 | 1,310 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 1,310 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 654 | $0.00 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 1,310 | $0.00 | 3,930 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | D | 1,847 | $60.15 | 198,916 | D | F |
| 12 Mar, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | D | 64,612 | $0.00 | 0 | D | M |
| 04 Mar, 2026 | Arthur Kuan | Common Stock | A | 102,871 | $1.72 | 139,022 | D | M |
| 04 Mar, 2026 | Arthur Kuan | Common Stock | D | 2,871 | $61.61 | 136,151 | D | F |
| 04 Mar, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | D | 102,871 | $0.00 | 64,612 | D | M |
| 09 Jan, 2026 | James Mulay | Common Stock | A | 654 | $3.72 | 654 | D | M |
| 09 Jan, 2026 | James Mulay | Common Stock | D | 654 | $44.16 | 0 | D | S |
| 09 Jan, 2026 | James Mulay | Common Stock | A | 10,491 | $12.59 | 10,491 | D | M |
| 09 Jan, 2026 | James Mulay | Common Stock | D | 10,491 | $52.99 | 0 | D | S |
| 09 Jan, 2026 | James Mulay | Director Stock Option (right to buy) | D | 654 | $0.00 | 1,308 | D | M |
| 09 Jan, 2026 | James Mulay | Director Stock Option (right to buy) | D | 10,491 | $0.00 | 5,240 | D | M |
| 24 Nov, 2025 | Christina Rossi | Director Stock Option (right to buy) | A | 20,889 | $0.00 | 20,889 | D | A |
| 09 Oct, 2025 | James Mulay | Common Stock | A | 5,903 | $3.72 | 5,903 | D | M |